5:2 Intermittent Fasting Protects Muscle and Liver in Obesity via Gut Microbiome
A 5:2 fasting protocol reversed muscle loss and liver fat in obese mice by reshaping gut bacteria and bile acid signaling.
Summary
Researchers at Harbin Medical University found that a 5:2 intermittent fasting regimen — two fasting days per week — significantly protected skeletal muscle quality and reduced liver fat in mice fed a high-fat diet. Despite consuming similar total calories as continuously overfed mice, the fasting group gained less weight, showed greater grip strength, and had larger muscle fibers. The benefits appeared to work through the gut: fasting reshaped the microbiome, boosting beneficial bacteria like Limosilactobacillus reuteri, strengthening the intestinal barrier, lowering inflammatory markers in blood, and activating bile acid receptor pathways in the liver and muscle. Free fatty acid accumulation in both tissues was also reduced. The findings suggest 5:2 fasting may offer a practical dietary strategy to simultaneously address fatty liver disease and the muscle wasting that often accompanies it.
Detailed Summary
Metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly known as non-alcoholic fatty liver disease — affects hundreds of millions of people worldwide and is closely tied to obesity, poor diet, and aging. One underappreciated consequence of MASLD is progressive skeletal muscle deterioration, which compounds frailty risk as people age. Finding dietary strategies that protect both the liver and muscle simultaneously is a high priority in longevity medicine.
In this mouse study, male C57BL/6J mice were first fed a 45% high-fat diet for 14 weeks to establish MASLD. They were then randomized to continue the high-fat diet or switch to a 5:2 intermittent fasting protocol — two complete fasting days per week, with unrestricted high-fat diet access on the remaining five days — for 12 weekly cycles.
Despite no significant difference in total caloric intake between groups, the fasting mice showed substantially lower body weight, reduced liver steatosis and inflammation, and markedly improved skeletal muscle outcomes including greater grip strength and larger muscle cross-sectional area. Inflammatory gene expression in muscle tissue was significantly downregulated.
Critically, the gut microbiome emerged as a central mechanism. IF5:2 restructured the microbial community, enriching beneficial species and activating secondary bile acid biosynthesis pathways. The intestinal barrier was strengthened — evidenced by upregulated tight junction genes, a thicker colon wall, and lower circulating lipopolysaccharide (LPS). Bile acid receptors in the intestine, liver, and skeletal muscle were all upregulated, and free fatty acid levels in both liver and muscle were reduced, negatively correlating with bile acid receptor expression.
Limitations include the exclusively male, preclinical mouse model and abstract-only access, meaning mechanistic details and statistical depth cannot be fully evaluated. Human trials are needed to confirm these promising dual-organ benefits.
Key Findings
- 5:2 fasting improved grip strength and muscle fiber size in obese mice without reducing total calorie intake.
- Liver fat and inflammation were significantly reduced alongside skeletal muscle protection.
- Fasting reshaped gut microbiota, enriching beneficial bacteria including Limosilactobacillus reuteri.
- Intestinal barrier integrity improved, lowering blood LPS and systemic inflammation.
- Bile acid receptor signaling in liver and muscle was upregulated, linked to reduced free fatty acid accumulation.
Methodology
Male C57BL/6J mice were fed a 45% high-fat diet for 14 weeks to induce MASLD, then subjected to a 5:2 intermittent fasting regimen (2 fasting days per week) for 12 cycles. Outcomes included grip strength, tissue histology, serum biochemistry, gut metagenomic sequencing, qRT-PCR for bile acid and inflammatory gene expression, and targeted free fatty acid profiling in liver and muscle.
Study Limitations
The study was conducted entirely in male mice, limiting generalizability to women and humans. Full methodological and statistical details are unavailable as this summary is based on the abstract only. The caloric equivalence between groups complicates isolation of fasting-specific effects from other metabolic variables.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: